Barclays
BDSX icon

Barclays’s Biodesix BDSX Stock Holding History

Barclays’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.06K Buy
+313
New +$4.64K ﹤0.01% 4740
2025
Q4 		– Sell
-1
Closed -$8 – 5253
2025
Q3 		$8 Sell
1
-8
-89% -$62 ﹤0.01% 5403
2025
Q2 		$51 Sell
9
-2,763
-100% -$22.3K ﹤0.01% 5118
2025
Q1 		$34.7K Sell
2,772
-2,841
-51% -$54.5K ﹤0.01% 4687
2024
Q4 		$172K Buy
5,613
+4,461
+387% +$131K ﹤0.01% 4377
2024
Q3 		$41K Buy
1,152
+1,059
+1,139% +$36.4K ﹤0.01% 4790
2024
Q2 		$2.84K Sell
93
-372
-80% -$10.6K ﹤0.01% 4616
2024
Q1 		$13.3K Hold
465
– – ﹤0.01% 4788
2023
Q4 		$17.1K Buy
+465
New +$14.6K ﹤0.01% 4925
2023
Q3 		– Sell
-12
Closed -$304 – 4600
2023
Q2 		$304 Buy
+12
New +$360 ﹤0.01% 4405
2022
Q2 		– Sell
-114
Closed -$4K – 5021
2022
Q1 		$4K Buy
+114
New +$7.45K ﹤0.01% 4716

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Barclays's BDSX Position: Q2 2026 in Review

Barclays opened a new position in Biodesix (BDSX) in Q2 2026: 313 shares worth $7.06K. The stake represents ﹤0.01% of the portfolio and ranks #4740 among its holdings. This is a return to the name: Barclays previously reported a position in BDSX as recently as Q3 2025.

Barclays first reported a position in BDSX in Q1 2022 and has held it in 11 quarters since. The position peaked at $172K in Q4 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Barclays held 313 shares of Biodesix worth $7.06K as of Q2 2026.
  • Biodesix was a new Barclays position in Q2 2026.
  • Biodesix made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4740 holding.
  • Barclays first reported a position in Biodesix in Q1 2022 and has held it in 11 quarters since.
  • Barclays's Biodesix position peaked at $172K in Q4 2024.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.